Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: Effect of Rabies Immunoglobulin on Immunogenicity of Post-exposure Rabies Vaccination in Obese Patients [NA]

View source ↗

Summary

A completed clinical trial assessed whether rabies immunoglobulin influences the immunogenicity of post-exposure rabies vaccination in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rabies immunoglobulin (HRIG) (Human rabies immunoglobulin)
  • Rabies vaccine (post-exposure) (Rabies vaccine)

Snippet

Sponsor: Mahidol University | Conditions: Rabies | NA | Status: COMPLETED